1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Dermatology OTC Medications Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Dermatology OTC Medications Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Dermatology OTC Medications Market Regional Analysis
6.2 North America Dermatology OTC Medications Market Revenue 2019-2028 (US$ Million)
6.3 North America Dermatology OTC Medications Market Forecast Analysis
7. North America Dermatology OTC Medications Market Analysis – by Product Type
7.1 Tablets and Capsules
- 7.1.1 Overview
- 7.1.2 Tablets and Capsules: North America Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Gels
- 7.2.1 Overview
- 7.2.2 Gels: North America Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Creams
- 7.3.1 Overview
- 7.3.2 Creams: North America Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Ointments
- 7.4.1 Overview
- 7.4.2 Ointments: North America Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Dermatology OTC Medications Market Analysis – by Route of Administration
8.1 Topical
- 8.1.1 Overview
- 8.1.2 Topical: North America Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Oral
- 8.2.1 Overview
- 8.2.2 Oral: North America Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Dermatology OTC Medications Market Analysis – by Indication
9.1 Dermatitis
- 9.1.1 Overview
- 9.1.2 Dermatitis: North America Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Acne
- 9.2.1 Overview
- 9.2.2 Acne: North America Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Psoriasis
- 9.3.1 Overview
- 9.3.2 Psoriasis: North America Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Skin Bleaching
- 9.4.1 Overview
- 9.4.2 Skin Bleaching: North America Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.5 Fungal Disease
- 9.5.1 Overview
- 9.5.2 Fungal Disease: North America Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.6 Warts
- 9.6.1 Overview
- 9.6.2 Warts: North America Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. North America Dermatology OTC Medications Market Analysis – by Distribution Channel
10.1 Online Distribution
- 10.1.1 Overview
- 10.1.2 Online Distribution: North America Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Offline Distribution
- 10.2.1 Overview
- 10.2.2 Offline Distribution : North America Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)
11. North America Dermatology OTC Medications Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America Dermatology OTC Medications Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 11.2.1.1 North America Dermatology OTC Medications Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America Dermatology OTC Medications Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 US: North America Dermatology OTC Medications Market Breakdown, by Product Type
- 11.2.1.1.2 US: North America Dermatology OTC Medications Market Breakdown, by Route of Administration
- 11.2.1.1.3 US: North America Dermatology OTC Medications Market Breakdown, by Indication
- 11.2.1.1.4 US: North America Dermatology OTC Medications Market Breakdown, by Distribution Channel
- 11.2.1.2 Canada:
North America Dermatology OTC Medications Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Canada: North America Dermatology OTC Medications Market Breakdown, by Product Type
- 11.2.1.2.2 Canada: North America Dermatology OTC Medications Market Breakdown, by Route of Administration
- 11.2.1.2.3 Canada: North America Dermatology OTC Medications Market Breakdown, by Indication
- 11.2.1.2.4 Canada: North America Dermatology OTC Medications Market Breakdown, by Distribution Channel
- 11.2.1.3 Mexico :
North America Dermatology OTC Medications Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Mexico : North America Dermatology OTC Medications Market Breakdown, by Product Type
- 11.2.1.3.2 Mexico : North America Dermatology OTC Medications Market Breakdown, by Route of Administration
- 11.2.1.3.3 Mexico : North America Dermatology OTC Medications Market Breakdown, by Indication
- 11.2.1.3.4 Mexico : North America Dermatology OTC Medications Market Breakdown, by Distribution Channel
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Acella Pharmaceuticals, LLC
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Bausch Health Companies Inc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Bayer AG
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Dr. Reddy's Laboratories
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Galderma
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 GlaxoSmithKline plc.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Johnson and Johnson Services, Inc.
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 LEO Pharma A/S
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Perrigo Company plc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Viatris Inc.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For North America Dermatology OTC Medications Market
